Stock listing

gettex:ER4 Emergent BioSolutions Inc. Aktie

German listing (gettex) of Emergent BioSolutions Inc. · home listing NYSE:EBS

Follow Emergent BioSolutions Inc. into a list and get an email when it puts out news.

Home listing price · NYSE:EBS

$6.38 USD -0.80 (-11.1%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NYSE:EBS

Emergent BioSolutions Inc. logo
Ticker
gettex:ER4
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
gettex
Currency
EUR

What changed lately

Calls

Replays

  • Emergent Biosolutions (NYSE:EBS) Q2 2026 Earnings Call

    Wed, Aug 05, 2026 · 5:00 PM ET

    Watch Transcript

  • Emergent Biosolutions (NYSE:EBS) Q1 2026 Earnings Call

    Thu, Apr 30, 2026 · 5:00 PM ET

    Watch Transcript

  • Emergent Biosolutions (NYSE:EBS) Q4 2025 Earnings Call

    Thu, Feb 26, 2026 · 5:00 PM ET

    Watch Transcript

Latest news

Emergent BioSolutions Announces Retirement of Chief Financial Officer Richard S. Lindahl

Oct 16, 2026

Emergent BioSolutions to Report Third Quarter 2026 Financial Results on November 2, 2026

Oct 15, 2026

Media Advisory: Emergent to Host Ribbon Cutting Ceremony at Canton Manufacturing Facility

Sep 15, 2026

Emergent BioSolutions Completes Repurchase of $75 Million Aggregate Principal Amount of Senior Unsecured Notes

Sep 3, 2026

Emergent BioSolutions Awarded Contract Modification Valued at Approximately $24 Million for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)

Sep 1, 2026

Emergent BioSolutions Awarded Government of Canada Standing Offer for NARCAN® Nasal Spray

Aug 31, 2026

Emergent BioSolutions Reinforces Commitment to Opioid Overdose Education and Preparedness on International Overdose Awareness Day

Aug 31, 2026

Emergent BioSolutions Commits to Cross-Sector Collaboration Against Biological Threats in an Evolving Global Security Environment

Aug 5, 2026

Emergent BioSolutions to Report Second Quarter 2026 Financial Results on August 5, 2026

Jul 22, 2026

Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government

Jun 29, 2026

All Emergent BioSolutions Inc. news

Decks

Emergent BioSolutions Inc. on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
37 in the last 12 months · 67 in all · newest Oct 16, 2026 · oldest 2025
Calls
25 calls with a replay · 25 with a transcript · latest Aug 5, 2026
Decks
45 decks · latest Sep 14, 2026

Where Emergent BioSolutions Inc. is listed

ListingExchangeCountryCurrency
NYSE:EBS · Home listingNYSEUnited StatesUSD
gettex:ER4 · This pagegettexGermanyEUR
Stuttgart:ER4StuttgartGermanyEUR
Tradegate:ER4TradegateGermanyEUR
Lang & Schwarz:A0LC2WLang & SchwarzGermanyEUR
LS Exchange:A0LC2WLS ExchangeGermanyEUR
LSE:0IGALSEUnited KingdomUSD
Frankfurt:ER4FrankfurtGermanyEUR
BOATS:EBSBOATSUnited StatesUSD
BX Swiss:ER4BX SwissSwitzerlandCHF
Dusseldorf:ER4DusseldorfGermanyEUR
Munich:ER4MunichGermanyEUR

Log in to ask 6ix AI your own questions about Emergent BioSolutions Inc.